Table 2A. Cross-tables of expression of YBX1c and YBX1n.
| Parameter | Total (%) | YBX1c positive (%) | YBX1c negative (%) | P-value | YBX1n positive (%) | YBX1n negative (%) | P-value |
|---|---|---|---|---|---|---|---|
| All cases | 423 (100) | 327 (77) | 96 (23) | 293 (69) | 130 (31) | ||
| Age | |||||||
| >72 | 238 (56) | 192 (81) | 46 (19) | 0.061 | 172 (72) | 66 (28) | 0.129 |
| <72 | 185 (44) | 135 (73) | 50 (27) | 121 (65) | 64 (35) | ||
| Gender | |||||||
| Male | 235 (56) | 186 (79) | 49 (21) | 0.311 | 158 (67) | 77 (33) | 0.311 |
| Female | 188 (44) | 141 (75) | 47 (25) | 135 (72) | 53 (28) | ||
| pT status | |||||||
| pT1/pT2 | 98 (23) | 77 (79) | 21 (21) | 0.697 | 71 (72) | 27 (28) | 0.48 |
| pT3/pT4 | 313 (74) | 240 (77) | 73 (23) | 215 (69) | 98 (31) | ||
| Nodal status | |||||||
| N0 | 214 (51) | 167 (78) | 47 (22) | 0.716 | 149 (70) | 65 (30) | 0.871 |
| N1 | 209 (49) | 160 (77) | 49 (23) | 144 (69) | 65 (31) | ||
| Metastasis | |||||||
| M0 | 369 (87) | 289 (78) | 80 (22) | 0.193 | 262 (71) | 107 (29) | 0.043 |
| M1 | 54 (13) | 38 (70) | 16 (30) | 31 (57) | 23 (43) | ||
| Grade | |||||||
| G1 | 4 (1) | 2 (50) | 2 (50) | 0.177 | 1 (25) | 3 (75) | 0.054 |
| G2/G3 | 412 (98) | 322 (78) | 90 (22) | 287 (70) | 125 (30) | ||
| R status | |||||||
| R0 | 377 (89) | 290 (77) | 87 (23) | 0.126 | 263 (70) | 114 (30) | 0.876 |
| R1 | 22 (5) | 20 (90) | 2 (10) | 15 (68) | 7 (32) | ||
| Localization | |||||||
| Right colon | 175 (41) | 136 (78) | 39 (22) | 0.845 | 118 (67) | 57 (33) | 0.235 |
| Left colon | 225 (53) | 173 (77) | 52 (23) | 164 (73) | 61 (27) | ||
| KRAS status | |||||||
| WT | 327 (77) | 255 (78) | 72 (22) | 0.836 | 227 (69) | 100 (31) | 0.954 |
| MUT | 53 (13) | 42 (79) | 11 (21) | 37 (70) | 16 (30) | ||